Schulz WA - Search Results

1

Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.

Koutsogiannouli EA, Wagner N, Hader C, Pinkerneil M, Hoffmann MJ, Schulz WA. Koutsogiannouli EA, et al. Among authors: schulz wa. Int J Mol Sci. 2017 Jul 5;18(7):1449. doi: 10.3390/ijms18071449. Int J Mol Sci. 2017. PMID: 28678170 Free PMC article.

2

Multiple mechanisms mediate resistance to sorafenib in urothelial cancer.

Knievel J, Schulz WA, Greife A, Hader C, Lübke T, Schmitz I, Albers P, Niegisch G. Knievel J, et al. Among authors: schulz wa. Int J Mol Sci. 2014 Nov 7;15(11):20500-17. doi: 10.3390/ijms151120500. Int J Mol Sci. 2014. PMID: 25387078 Free PMC article.

3

Epigenetics of urothelial carcinoma.

Schulz WA, Koutsogiannouli EA, Niegisch G, Hoffmann MJ. Schulz WA, et al. Methods Mol Biol. 2015;1238:183-215. doi: 10.1007/978-1-4939-1804-1_10. Methods Mol Biol. 2015. PMID: 25421661 Review.

4

Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.

Pinkerneil M, Hoffmann MJ, Deenen R, Köhrer K, Arent T, Schulz WA, Niegisch G. Pinkerneil M, et al. Among authors: schulz wa. Mol Cancer Ther. 2016 Feb;15(2):299-312. doi: 10.1158/1535-7163.MCT-15-0618. Epub 2016 Jan 15. Mol Cancer Ther. 2016. PMID: 26772204

5

Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.

Isono M, Hoffmann MJ, Pinkerneil M, Sato A, Michaelis M, Cinatl J Jr, Niegisch G, Schulz WA. Isono M, et al. Among authors: schulz wa. J Exp Clin Cancer Res. 2017 Jan 3;36(1):1. doi: 10.1186/s13046-016-0473-1. J Exp Clin Cancer Res. 2017. PMID: 28049532 Free PMC article.

6

Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines.

Skowron MA, Niegisch G, Albrecht P, van Koeveringe G, Romano A, Albers P, Schulz WA, Hoffmann MJ. Skowron MA, et al. Among authors: schulz wa. Int J Mol Sci. 2017 Aug 2;18(8):1680. doi: 10.3390/ijms18081680. Int J Mol Sci. 2017. PMID: 28767070 Free PMC article.

7

Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines.

Skowron MA, Melnikova M, van Roermund JGH, Romano A, Albers P, Thomale J, Schulz WA, Niegisch G, Hoffmann MJ. Skowron MA, et al. Among authors: schulz wa. Int J Mol Sci. 2018 Feb 16;19(2):590. doi: 10.3390/ijms19020590. Int J Mol Sci. 2018. PMID: 29462944 Free PMC article.

8

Effects of novel HDAC inhibitors on urothelial carcinoma cells.

Kaletsch A, Pinkerneil M, Hoffmann MJ, Jaguva Vasudevan AA, Wang C, Hansen FK, Wiek C, Hanenberg H, Gertzen C, Gohlke H, Kassack MU, Kurz T, Schulz WA, Niegisch G. Kaletsch A, et al. Among authors: schulz wa. Clin Epigenetics. 2018 Jul 31;10(1):100. doi: 10.1186/s13148-018-0531-y. Clin Epigenetics. 2018. PMID: 30064501 Free PMC article.

9

HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition.

Jaguva Vasudevan AA, Hoffmann MJ, Beck MLC, Poschmann G, Petzsch P, Wiek C, Stühler K, Köhrer K, Schulz WA, Niegisch G. Jaguva Vasudevan AA, et al. Among authors: schulz wa. Int J Mol Sci. 2019 Apr 30;20(9):2135. doi: 10.3390/ijms20092135. Int J Mol Sci. 2019. PMID: 31052182 Free PMC article.

10

Many Different LINE-1 Retroelements Are Activated in Bladder Cancer.

Whongsiri P, Goering W, Lautwein T, Hader C, Niegisch G, Köhrer K, Hoffmann MJ, Schulz WA. Whongsiri P, et al. Among authors: schulz wa. Int J Mol Sci. 2020 Dec 11;21(24):9433. doi: 10.3390/ijms21249433. Int J Mol Sci. 2020. PMID: 33322422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters